Bfsg, LLC Abb Vie Inc. Transaction History

Bfsg, LLC

$843 Million
Q3 2024

A detailed history of Bfsg, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Bfsg, LLC holds 24,047 shares of ABBV stock, worth $4.22 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

24,047

Previous 25,498 5.69%

Holding current value

$4.22 Million

Previous $4.37 Million 8.58%

% of portfolio

0.56%

Previous 0.56%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$163.84 - $199.33 $237,731 - $289,227	-1,451 Reduced 5.69%	24,047 $4.75 Million
Q2 2024 Jul 29, 2024	SELL	$154.79 - $180.76 $60,832 - $71,038	-393 Reduced 1.52%	25,498 $4.37 Million
Q1 2024 Apr 23, 2024	SELL	$159.82 - $182.1 $4,315 - $4,916	-27 Reduced 0.1%	25,891 $4.71 Million
Q4 2023 Feb 01, 2024	SELL	$137.6 - $154.97 $33,024 - $37,192	-240 Reduced 0.92%	25,918 $4.02 Million
Q3 2023 Oct 20, 2023	BUY	$133.59 - $154.65 $132,654 - $153,567	993 Added 3.95%	26,158 $3.9 Million
Q2 2023 Aug 07, 2023	BUY	$132.51 - $164.9 $45,715 - $56,890	345 Added 1.39%	25,165 $3.39 Million
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $4,916 - $5,662	34 Added 0.14%	24,820 $3.96 Million
Q4 2022 Feb 01, 2023	BUY	$138.31 - $165.87 $23,512 - $28,197	170 Added 0.69%	24,786 $4.01 Million
Q3 2022 Nov 07, 2022	BUY	$134.21 - $153.93 $34,894 - $40,021	260 Added 1.07%	24,616 $3.3 Million
Q2 2022 Aug 04, 2022	BUY	$137.62 - $174.96 $9,908 - $12,597	72 Added 0.3%	24,356 $3.73 Million
Q1 2022 May 04, 2022	SELL	$131.98 - $163.75 $97,929 - $121,502	-742 Reduced 2.96%	24,284 $3.94 Million
Q4 2021 Jan 24, 2022	SELL	$107.43 - $135.93 $32,551 - $41,186	-303 Reduced 1.2%	25,026 $3.39 Million
Q3 2021 Nov 03, 2021	BUY	$106.4 - $120.78 $53,093 - $60,269	499 Added 2.01%	25,329 $2.73 Million
Q2 2021 Jul 29, 2021	SELL	$105.21 - $117.21 $29,037 - $32,349	-276 Reduced 1.1%	24,830 $2.8 Million
Q1 2021 Apr 26, 2021	SELL	$102.3 - $112.62 $103,323 - $113,746	-1,010 Reduced 3.87%	25,106 $2.72 Million
Q4 2020 Jan 26, 2021	BUY	$80.49 - $108.67 $20,122 - $27,167	250 Added 0.97%	26,116 $2.8 Million
Q3 2020 Nov 04, 2020	BUY	$85.91 - $100.83 $27,663 - $32,467	322 Added 1.26%	25,866 $2.27 Million
Q2 2020 Jul 22, 2020	BUY	$73.37 - $98.18 $24,945 - $33,381	340 Added 1.35%	25,544 $2.51 Million
Q1 2020 Apr 27, 2020	BUY	$64.5 - $97.79 $903 - $1,369	14 Added 0.06%	25,204 $1.92 Million
Q4 2019 Jan 29, 2020	BUY	$72.13 - $90.25 $5,481 - $6,859	76 Added 0.3%	25,190 $2.23 Million
Q3 2019 Oct 25, 2019	SELL	$62.98 - $75.72 $13,162 - $15,825	-209 Reduced 0.83%	25,114 $1.9 Million
Q2 2019 Jul 30, 2019	SELL	$65.7 - $83.98 $12,417 - $15,872	-189 Reduced 0.74%	25,323 $1.84 Million
Q1 2019 Apr 18, 2019	SELL	$77.14 - $90.79 $97,967 - $115,303	-1,270 Reduced 4.74%	25,512 $2.06 Million
Q4 2018 Jan 24, 2019	SELL	$77.85 - $96.01 $66,172 - $81,608	-850 Reduced 3.08%	26,782 $2.47 Million
Q3 2018 Oct 18, 2018	SELL	$88.91 - $98.84 $43,743 - $48,629	-492 Reduced 1.75%	27,632 $2.61 Million
Q2 2018 Jul 31, 2018	BUY	$89.78 - $106.23 $5,297 - $6,267	59 Added 0.21%	28,124 $2.61 Million
Q1 2018 May 08, 2018	SELL	$92.01 - $123.21 $61,278 - $82,057	-666 Reduced 2.32%	28,065 $2.66 Million
Q4 2017 Jan 23, 2018	SELL	$89.56 - $98.21 $142,758 - $156,546	-1,594 Reduced 5.26%	28,731 $2.78 Million
Q3 2017 Oct 12, 2017	SELL	$69.85 - $89.22 $37,649 - $48,089	-539 Reduced 1.75%	30,325 $2.7 Million
Q2 2017 Aug 10, 2017	BUY	N/A	30,864	30,864 $2.24 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bfsg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bfsg, LLC with notifications on news.

Account